Cleared Traditional

K843109 - ROCHE REAGENT FOR AST

K843109 is an FDA 510(k) clearance for ROCHE REAGENT FOR AST, manufactured by Roche Diagnostic Systems, Inc.. The device is a Class 2 Chemistry device with product code CIT cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K843109 · Roche Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1984
Decision
90d
Days
Class 2
Risk

K843109 is an FDA 510(k) clearance for the ROCHE REAGENT FOR AST. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Roche Diagnostic Systems, Inc. (Nutley, US). The FDA issued a Cleared decision on November 5, 1984 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostic Systems, Inc. devices

FDA 510(k) Submission Details - K843109

510(k) Number K843109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 1984
Decision Date November 05, 1984
Days to Decision 90 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 88d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CIT Device Classification - Class 2, Special Controls

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 130
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K843109.
AST ASPARTATE AMINOTRANSFERASE REAGENT
K851994 · Alpkem Corp. · Jun 1985
AMRESCO FLOW PAC SMA PHOSPHATE BUFFER CONCENTRATE
K851865 · Amresco, Inc. · May 1985
GEMENI AST-LTS REAGENTS
K851267 · Electro-Nucleonics Laboratories, Inc. · Apr 1985
SYSTEMATE GOT 67208
K843333 · Em Diagnostic Systems, Inc. · Sep 1984
SIGMA 58-UV ASPARTATE AMINOTRANSFERAS
K842411 · Sigma Chemical Co. · Aug 1984
ASPARTATE AMINOTRANSFERASE ASSAY KIT
K842245 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984